Multi-talented ibudilast debuts on new clinical stage
This article was originally published in Scrip
Executive Summary
Ibudilast's multiple modes of action are being investigated in another new setting, this time for medication overuse headache (MOH) in a Phase II clinical trial now starting in Australia.